BRUNELLI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 160
AS - Asia 96
EU - Europa 91
SA - Sud America 12
AF - Africa 1
Totale 360
Nazione #
US - Stati Uniti d'America 154
CN - Cina 41
IE - Irlanda 38
SG - Singapore 27
HK - Hong Kong 17
FI - Finlandia 14
RU - Federazione Russa 13
BR - Brasile 11
IT - Italia 9
DE - Germania 4
VN - Vietnam 4
CA - Canada 3
MX - Messico 3
AT - Austria 2
CZ - Repubblica Ceca 2
ES - Italia 2
GB - Regno Unito 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 360
Città #
Dublin 38
Chandler 33
Beijing 22
Hong Kong 17
Ashburn 15
Helsinki 14
Boardman 7
Los Angeles 7
Shanghai 7
Singapore 7
Dallas 6
Lawrence 6
Princeton 6
Wilmington 6
Medford 5
Pavia 4
San Francisco 3
Buffalo 2
Columbus 2
Dearborn 2
Ho Chi Minh City 2
Moscow 2
Munich 2
New York 2
Olomouc 2
Pognana Lario 2
Redondo Beach 2
Santa Clara 2
São Paulo 2
The Dalles 2
Vienna 2
Bauru 1
Boston 1
Brooklyn 1
Cambridge 1
Canavieiras 1
Chennai 1
Concepción 1
Crosby 1
Cuauhtémoc 1
Edmonton 1
Falkenstein 1
Friesland 1
Getúlio Vargas 1
Goiânia 1
Hefei 1
Houston 1
Iretama 1
Jakarta 1
Jiaxing 1
Johannesburg 1
Lins 1
London 1
Lorena 1
Madrid 1
Manaus 1
Nuremberg 1
Orem 1
Phoenix 1
Poplar 1
Queens 1
Raleigh 1
Santana do Livramento 1
Shantou 1
Shymkent 1
Stockholm 1
Thái Nguyên 1
Tlalpan 1
Tokyo 1
Toronto 1
Warsaw 1
Washington 1
Woodbridge 1
Yerevan 1
Zhengzhou 1
Totale 275
Nome #
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) 71
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises 68
Reprofiling metastatic samples for chromosome 9p and 14q aberrations as a strategy to overcome tumor heterogeneity in clear-cell renal cell carcinoma 64
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 57
The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 54
Wide spetcrum mutational analysis of metastatic renal cell cancer: A retrospective next generation sequencing approach 53
Totale 367
Categoria #
all - tutte 2.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 1 2 0 0 0 0
2021/202223 3 0 0 0 0 0 1 4 1 1 1 12
2022/2023101 11 7 2 8 6 9 0 10 46 0 2 0
2023/202431 6 6 1 0 0 8 3 0 0 1 4 2
2024/202583 5 6 2 0 0 7 2 11 17 5 14 14
2025/2026106 16 15 24 18 28 5 0 0 0 0 0 0
Totale 367